Key result
Intrathecal dexmedetomidine reduces time to T10 dermatome by ~18% versus bupivacaine alone.
Why the study?
The study was conducted to compare the effects of adding dexmedetomidine 10 mcg or magnesium sulphate 50mg to 0.5% hyperbaric bupivacaine on subarachnoid block characteristics and postoperative analgesia during elective lower extremity surgeries.
Does adding dexmedetomidine or magnesium sulphate to bupivacaine improve block characteristics and analgesia in patients undergoing lower extremity surgeries?
RCT (n=90)
Double-blind
Computer generated random numbers
No
Does adding dexmedetomidine or magnesium sulphate to bupivacaine improve block characteristics and analgesia in patients undergoing lower extremity surgeries?
Adding dexmedetomidine to intrathecal bupivacaine improves the onset and duration of sensory and motor block in patients undergoing lower extremity surgeries.
Answers are grounded in this paper and cite their sources.
Dexmedetomidine improves spinal block onset, duration, and analgesia versus magnesium; extends RCT evidence for intrathecal adjuvant choice.
In this prospective randomised double blind study, an attempt was made to compare the effects of adding dexmedetomidine 10 mcg or magnesium sulphate 50mg to 0.5% hyperbaric bupivacaine on subarachnoid block characteristics and postoperative analgesia in patients undergoing elective lower extremity surgeries. Randomization of the participants was done in three equal groups (n=30). A total of 90 patients of age between 18-60 years of either sex and good physical status posted for elective lower extremity surgery were included. Group B received 15 mg hyperbaric bupivacaine(3ml) with 0.5ml preservative free normal saline,Group D received 15 mg hyperbaric bupivacaine (3ml) with 10 mcg dexmedetomidine in 0.5 ml preservative free normal saline intrathecally and Group M received 15 mg hyperbaric bupivacaine (3ml) with 50mg magnesium sulphate (0.5ml) intrathecally for subarachnoid block. Different parameters of sensory block, motor block and analgesia effect were assessed as outcomes. Results showed that the groups were similar in demographic parameters like age, sex, height, weight, physical status. Bupivacaine with dexmedetomidine as adjuvant shows early onset of sensory and motor block, early onset of peak block height, prolonged sensory block, prolonged two segment regression time.
No takes yet. Share an insight, caveat, or question.
Padhi et al. (2022) conducted an RCT in Elective lower extremity surgeries (n=90). Dexmedetomidine vs. Bupivacaine alone (Control) or Bupivacaine with Magnesium Sulphate was evaluated on Time to reach T10 dermatome (minutes) (p=<0.01). Intrathecal administration of dexmedetomidine with bupivacaine reduced the time to reach T10 dermatome to 3.6 minutes compared to 4.4 minutes with bupivacaine alone.
Synapse has enriched 10 related papers. Consider them for comparative context: